Accessibility Menu

Valerio Therapeutics Société Anonyme(FRA) C4X

Market Cap€445.05MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€0.73
-4.06%
-0.03Today

Valerio Therapeutics Société Anonyme Financials at a Glance

Market Cap

€445.05MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

-€0.02

P/E Ratio

-43.80

Dividend

€0.00

Beta (Volatility)

-0.26 (Low)

Price

€0.73

Volume

600

Open

€0.76

Previous Close

€0.73

Daily Range

€0.73 - €0.76

52-Week Range

€0.04 - €0.93

Estimated Earnings Date

N/A

C4X News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Valerio Therapeutics Société Anonyme

Onxeo SA is a is a clinical-stage biotechnology company, which engages in the development of drugs for the treatment of orphan diseases. The firm produces and develops orphan oncology products under the brand names Livatag, Validive, Beleodaq and AsiDNA. The company was founded by Jean Theron, Gilles Avenard, and Dominique Costantini on March 5, 1997 and is headquartered in Paris, France.

Industry

Biotechnology

Sector

Health Care

Employees

35

CEO

Julien Miara

Website

www.valeriotx.com

C4X Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-2.28%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€445.05MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

567.67M

Volume

600

Avg. Volume

4.60K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Valerio Therapeutics Société Anonyme Performance Analysis

Valerio Therapeutics Société Anonyme annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 1,443,000-64.5%
20232023-12-31EUR 1,800,00024.7%
20242024-12-31EUR 1,793,000-0.4%
20252025-12-31EUR 2,573,00043.5%
Valerio Therapeutics Société Anonyme annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR -0.19174.9%
20232023-12-31EUR -0.15-18.6%
20242024-12-31EUR -0.163.3%
20252025-12-31EUR -0.02-88.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

€445.05MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About C4X

What is the current price of Valerio Therapeutics Société Anonyme?

Valerio Therapeutics Société Anonyme is trading at €0.73 per share.

What is the 52-week range for Valerio Therapeutics Société Anonyme?

Over the past 52 weeks, Valerio Therapeutics Société Anonyme has traded between €0.04 and €0.93.

How much debt does Valerio Therapeutics Société Anonyme have?

As of the most recent reporting period, Valerio Therapeutics Société Anonyme reported total debt of €7.60M.

How much cash does Valerio Therapeutics Société Anonyme have on hand?

Valerio Therapeutics Société Anonyme reported €1.05M in cash and cash equivalents in its most recent financial results.

What is Valerio Therapeutics Société Anonyme’s dividend yield?

Valerio Therapeutics Société Anonyme does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services